Linda Yaccarino, the former X CEO who left the social media company last month in the wake of yet another Elon Musk controversy, has been named the top executive at health company eMed.

eMed Population Health provides support for patients on GLP-1 medications, such as Wegovy and Ozempic, that treat diabetes and obesity.

“Our mission is revolutionizing how people receive safe, effective care for chronic condition management through GLP-1 therapies, while building the programs and technologies needed to sustain lasting health outcomes,” Yaccarino wrote in a post on Tuesday announcing her new role as CEO .

“This is truly a transformational moment in preventative healthcare, and I’m energized by the opportunity to help lead what could become the most impactful health initiative of our

See Full Page